Survivorship care for patients curatively treated for Hodgkin's and non-Hodgkin's lymphoma: a scoping review
M Powis, S Hack, R Fazelzad, D Hodgson… - Journal of Cancer …, 2023 - Springer
Purpose We undertook a scoping review of the literature to synthesize what is known about
lymphoma survivorship and develop a comprehensive set of lymphoma-specific survivorship …
lymphoma survivorship and develop a comprehensive set of lymphoma-specific survivorship …
[HTML][HTML] Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of …
Lymphoma survivors after high-dose therapy with autologous stem-cell transplant (HDT-
ASCT) are at risk of several late effects, which might impair their health-related quality of life …
ASCT) are at risk of several late effects, which might impair their health-related quality of life …
The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study
MA Pedersen, LC Gormsen… - British Journal of …, 2024 - Wiley Online Library
Standard CHOP treatment includes a high cumulative dose of prednisone, and studies have
shown increased fracture risk following CHOP. It is unclear whether reductions in bone …
shown increased fracture risk following CHOP. It is unclear whether reductions in bone …
A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment
Lymphoma patients often receive high glucocorticoid doses as part of standard therapy.
Observational studies have shown a substantial risk of glucocorticoid-induced osteoporosis …
Observational studies have shown a substantial risk of glucocorticoid-induced osteoporosis …
Low bone mineral density and high bone turnover in patients with Non-Hodgkin's Lymphoma (NHL) who receive frontline therapy: results of a multicenter prospective …
K Anargyrou, D Fotiou, TP Vassilakopoulos… - …, 2019 - journals.lww.com
Chemotherapy associated osteoporosis is a severe problem in patients with malignant
diseases as it increases the risk for fractures and deteriorates quality of life. There are very …
diseases as it increases the risk for fractures and deteriorates quality of life. There are very …
Факторы, влияющие на ремоделирование костной ткани, у больных лимфомой Ходжкина (обзор литературы)
МС Войтко, ТИ Поспелова, ВВ Климонтов… - Сибирский научный …, 2018 - cyberleninka.ru
В настоящее время лимфома Ходжкина признана потенциально излечимым
заболеванием, при применении современных программ химиотерапии могут быть …
заболеванием, при применении современных программ химиотерапии могут быть …
Increased risk of hip fracture in patients with lymphoma, a Swedish population study of 37,236 lymphoma patients
P Johansson, H Lind Kristjansdottir… - Calcified Tissue …, 2020 - Springer
Increased bone loss has been noted in lymphoma patients; however, the incidence of hip
fracture is not known. The aim of our study was to explore the risk for hip fracture in patients …
fracture is not known. The aim of our study was to explore the risk for hip fracture in patients …
Osteometabolic changes in patients under antineoplastic treatment: scoping review
LDA Rezende, D de Souza Catabriga… - Health Sciences …, 2023 - portalrcs.hcitajuba.org.br
Objective: To summarize the main evidence regarding osteometabolic changes in patients
undergoing antineoplastic treatment. Methods: This is a scoping review, following the …
undergoing antineoplastic treatment. Methods: This is a scoping review, following the …
Blood and Bone-Epidemiological studies on the association between blood and bone
HL Kristjansdottir - 2021 - gupea.ub.gu.se
Introduction: Preclinical and clinical studies have suggested that blood-and bone cells are
interconnected. Aims: To study the association between hematological variables, specifically …
interconnected. Aims: To study the association between hematological variables, specifically …
[HTML][HTML] FACTORS AFFECTING BONE REMODELING IN PATIENTS WITH HODGKIN'S LYMPHOMA
MS Voytko, TI Pospelova, VV Klimontov… - Сибирский научный …, 2018 - sibmed.elpub.ru
Hodgkin's lymphoma is considered a potentially curable disease. Chemotherapy-based
salvage regimens can achieve responses in 90% of patients with Hodgkin's lymphoma. The …
salvage regimens can achieve responses in 90% of patients with Hodgkin's lymphoma. The …